- Title
- Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer
- Creators
- Brenda W Cooper - Department of Medicine, University Hospitals of Cleveland, Cleveland, OH, United StatesTomas Radivoyevitch - Biostatistics and Epidemiology, Ireland Cancer Center, University Hospitals of Cleveland, Case School of Medicine, Cleveland, OH, United StatesBeth A Overmoyer - Department of Medicine, University Hospitals of Cleveland, Cleveland, OH, United StatesRobert R Shenk - Surgery, Ireland Cancer Center, University Hospitals of Cleveland, Case School of Medicine, Cleveland, OH, United StatesHuong T Pham - Radiation Oncology, Ireland Cancer Center, University Hospitals of Cleveland, Case School of Medicine, Cleveland, OH, United StatesJudith R Samuels - Radiation Oncology, Ireland Cancer Center, University Hospitals of Cleveland, Case School of Medicine, Cleveland, OH, United StatesMargaret P Parry - Department of Medicine, University Hospitals of Cleveland, Cleveland, OH, United StatesPaula Silverman - Department of Medicine, University Hospitals of Cleveland, Cleveland, OH, United States
- Publication Details
- Breast cancer research and treatment, Vol.97(3), pp.311-318
- Publisher
- Springer
- Language
- English
- Resource Type
- Journal article
- PMID
- 16344915
- Record Identifier
- 991031613380802976
Journal article
Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer
Breast cancer research and treatment, Vol.97(3), pp.311-318
2006
PMID: 16344915
Metrics
8 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.119 Breast Cancer Scanning
- 1.119.259 HER2
- Web Of Science research areas
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites